Stay updated on Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial
Sign up to get notified when there's something new on the Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial page.

Latest updates to the Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedAdded site revision tag v3.4.2 and removed older notices about government funding and operating status (revision v3.4.1); these are administrative updates and do not change the trial details or how users interact with the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH Clinical Center status with a reference for updates. Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check28 days agoChange DetectedUI and metadata labels were updated. The additions include 'Show glossary', 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'; the items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page.SummaryDifference0.0%

- Check63 days agoChange DetectedThe Locations section was expanded to include many new sites across the US, Canada, and internationally, and the HHS Vulnerability Disclosure link was removed.SummaryDifference2%

- Check91 days agoChange DetectedAn explanatory note was added stating that PubMed publications are automatically filled from PubMed and may not pertain to the study, and the revision tag was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial page.